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ABSTRACT
Current research suggests that physiological responses to hypobaric and
normobaric hypoxia may be different. It is unknown if these differences extend to
skeletal muscle and the transcriptional responses regulating muscle mass.
PURPOSE: To determine the effects of hypobaric and normobaric hypoxia on
myogenenic and proteolytic gene expression. METHODS: Recreationally trained
subjects (n= 15; age= 24 ± 4 y; VO2max= 3.60 ± 0.83 L · min-1) completed three
trials of 60-min cycling at 70% of Wmax followed by 4-h recovery at ambient
conditions (975 m), hypobaric hypoxia (4,420 m), and normobaric hypoxia (4,420
m). A muscle biopsy was taken from the vastus lateralis before exercise and at the
end of the 4-h recovery period in each trial for gene expression analysis (RTqPCR). RESULTS: There were no differences in the myogenic gene expression of
MYOD, MYF-5, or MYOG between trials (p > 0.05). MYF-6 was higher after
exercise (p = 0.002) regardless of trial. MSTN decreased pre- to post-exercise in
all conditions (p < 0.001) and was lower in hypobaric hypoxia compared to
control (p = 0.02) and normobaric conditions (p = 0.037). There were no
differences in the expression of atrogin-1 with exercise or between trials (p >
0.05). However, FOXO3 and MuRF-1 increased with exercise (p < 0.05) but were
not different between conditions (p > 0.05). CONCLUSION: These data indicate
that hypobaric and normobaric hypoxia during recovery from exercise does not
affect myogenic and proteolytic gene expression with the exception of a modest
attenuation of myostatin in hypobaric hypoxia.

INTRODUCTION
• It is well known that prolonged stays at altitude will decrease body mass.
• This decline is attributed to an increase in basal metabolic rates, reduction of
food intake, impairments in protein synthesis, and potential changes in gene
expression from hypoxia.

METHODS

• 8 recreationally trained male and 7 recreationally trained female subjects
completed 3 trials in a randomized, counter-balanced order.

• Subjects cycled for 1 h on an electronically braked cycle ergometer
(Velotron, RacerMate, Seattle, WA) followed by 4 hours of recovery at
simulated altitudes.
• Recovery altitudes consisted of ambient conditions (975 m), hypobaric
hypoxia (4,420 m), and normobaric hypoxia (4,420 m).
• Participants rested supine in an altitude tube (Engineering Innovations,
LLC, Littleton, CO) capable of lowering the barometric pressure.
• The altitude tube was located inside a hypoxic chamber (Tescor,
Warminster, PA) capable of lowering the percentage of oxygen in the air.
• Muscle biopsies were taken from the vastus lateralis before exercise and
after each recovery period for analyses of myogenic and proteolytic gene
expression.

RESULTS

• Recent literature suggests simulating high altitude through normobaric hypoxia
is physiologically different from hypobaric hypoxia.
• It is unknown, however, if these differences extend to the cellular level within
skeletal muscle tissue.
• Myogenic and proteolytic responses to these different forms of hypoxia may
give insight into potential physiological differences.
• The purpose of this research was to determine the differences in key myogenic
and proteolytic gene expression between hypobaric and normobaric hypoxia
after acute, aerobic exercise.

RESULTS

Table 1. Participant descriptive data (n = 15).
Age
(y)

Height
(cm)

Weight
(kg)

24 ± 4 178 ± 12 72.47 ± 13.84
Data are mean ± SD.

Body Fat VO2 Peak
-1
(%)
(L · min )
14 ± 7

3.6 ± 0.8

CONCLUSIONS
• Hypobaric and normobaric hypoxia recovery from aerobic exercise does not
affect myogenic and proteolytic gene expression with the exception of a modest
attenuation of myostatin in hypobaric hypoxia.
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